Cargando…
Needs assessment for novel Gram-negative antibiotics in US hospitals: a retrospective cohort study
BACKGROUND: Evidence-based needs assessments for novel antibiotics against highly-resistant Gram-negative infections (GNIs) are scarce. We aimed to use real-world data from an electronic health record repository to identify treatment opportunities in US hospitals for GNIs resistant to all first-line...
Autores principales: | Strich, Jeffrey R, Warner, Sarah, Lai, Yi Ling, Demirkale, Cumhur Y, Powers, John H, Danner, Robert L, Kadri, Sameer S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7272178/ https://www.ncbi.nlm.nih.gov/pubmed/32505231 http://dx.doi.org/10.1016/S1473-3099(20)30153-5 |
Ejemplares similares
-
2251. Estimating the Need for Novel Gram-Negative Active Antibiotics in US Hospitals
por: Strich, Jeffrey R, et al.
Publicado: (2019) -
1110. Why has Utilization of Novel Gram-negative Antibiotics been Sluggish in U.S. Hospitals? A Retrospective Cohort Study to Inform Future Antibiotic Development and Market Entry Rewards
por: Strich, Jeffrey R, et al.
Publicado: (2023) -
1333. Utility of Admission Procalcitonin Level in Patients Presenting to the Hospital with Bloodstream Infection: Real-World Evidence from 250 US Hospitals
por: Kadri, Sameer S, et al.
Publicado: (2019) -
1163. Impact of Difficult-to-Treat Resistance on Survival in Gram-Negative Bacteremia: A Risk-Adjusted Analysis Using Electronic Health Record-based Clinical Data From 140 US Hospitals
por: Kadri, Sameer S, et al.
Publicado: (2018) -
Real-World Inpatient Use of Medications Repurposed for Coronavirus Disease 2019 in United States Hospitals, March–May 2020
por: Kadri, Sameer S, et al.
Publicado: (2020)